검색결과 : 2건
No. | Article |
---|---|
1 |
miR-100-5p confers resistance to ALK tyrosine kinase inhibitors Crizotinib and Lorlatinib in EML4-ALK positive NSCLC Lai Y, Kacal M, Kanony M, Stukan I, Jatta K, Kis L, Norberg E, Vakifahmetoglu-Norberg H, Lewensohn R, Hydbring P, Ekman S Biochemical and Biophysical Research Communications, 511(2), 260, 2019 |
2 |
miR-126-5p targets Malate Dehydrogenase 1 in non-small cell lung carcinomas Queiroz AL, Zhang BX, Comstock DE, Hao YQ, Eriksson M, Hydbring P, Vakifahmetoglu-Norberg H, Norberg E Biochemical and Biophysical Research Communications, 499(2), 314, 2018 |